Lin Sue-Jean
- SEC CIK
- 0001867788
In the past year, 2 open-market sale filings worth $898.5K and no purchases.
Current role at each company
- STVN Stevanato Group S.p.A.Directoras of Jun 26, 2026
- ARQT Arcutis Biotherapeutics, Inc.Directoras of Jun 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $898.5K
- 2 filings
- Net
- −$898.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lin Sue-Jean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARQT Arcutis Biotherapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Lin Sue-JeanDirector | SSale | −4.95K | $24.38 | −$120.6K | −15.2%27.6K after | 10b5-1 |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Lin Sue-JeanDirector | SSale | −25.3K | $30.78 | −$777.9K | −48.6%26.7K after |